Want to receive the latest Esophageal Cancer news delivered to your inbox?
Use the form below to never miss an important update from the medical community about Esophageal Cancer, new studies and developments.
New Discovery: Inherited Gene Mutation linked to Esophageal Adenocarcinoma
A breakthrough by researchers at Case Western Reserve has led to the discovery of an [...]
Potential “Game Changer” for Esophageal Cancer Patients: Vitamin D can Play a Significant Role in Survival for Many Patients with Both Major Types of Esophageal Cancer
A recent analysis found that the use of Vitamin D supplements significantly reduced the risk [...]
Genetic Game-Changer?
A new study finds that 9% of all Esophageal Adenocarcinoma (EAC) patients have mutations in [...]
New, Free Clinical Trials Matching
ECAN is proud to launch a new, personalized service to match Esophageal Cancer patients [...]
Beta Blockers to Improve Immunotherapy Response
Less than a third of Esophageal Cancer Patients Respond to Immunotherapy. Could a Medication [...]
Study finds Drug Increases Appetite, Weight Gain for Cancer Patients
Low doses of an inexpensive, well-tolerated drug were found to increase the appetite, weight gain, [...]
Bariatric Surgery may increase Risk of Precursor of Esophageal Cancer
Study finds bariatric surgery known as sleeve gastrectomy increases the risk of Barrett’s Esophagus, the [...]
Sleep Habits Affect Risk of Esophageal Cancer
Study finds Sleep Habits affect Risk of Esophageal Cancer. Researchers at Washington University School [...]
Campaign for Esophageal Cancer Research Funding
Over the past two years, more than $11 million in new federal funding has been [...]
Preventing Chemo Brain? Study Identifies Potential Approach for Common Problem
A side effect of some cancer treatments commonly referred to as “chemo brain” has received [...]
Groundbreaking Study on How Barrett’s Esophagus becomes Cancer
A new study from Great Britain underscores the importance of early detection of Barrett's Esophagus [...]
Three New Immunotherapy Indications for Esophageal Cancer Patients
Since March 2021, the U.S. Food and Drug Administration has issued four approvals for PD-L1 [...]